HK Stock MarketDetailed Quotes

02666 UNI MEDICAL

Watchlist
  • 4.660
  • +0.010+0.22%
Market Closed Nov 25 16:08 CST
8.81BMarket Cap3.90P/E (TTM)

UNI MEDICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
-2.91%6.54B
13.06%13.65B
17.98%6.74B
21.78%12.07B
14.07%5.71B
16.35%9.91B
24.44%5.01B
25.03%8.52B
25.94%4.02B
58.62%6.82B
Operating income
-2.91%6.54B
13.06%13.65B
17.98%6.74B
21.78%12.07B
14.07%5.71B
16.35%9.91B
24.44%5.01B
25.03%8.52B
25.94%4.02B
58.62%6.82B
Cost of sales
4.19%-4.28B
-19.78%-9.08B
-34.05%-4.47B
-32.62%-7.58B
-26.01%-3.33B
-15.05%-5.71B
-14.44%-2.64B
-36.59%-4.97B
-49.02%-2.31B
-113.23%-3.64B
Operating expenses
4.19%-4.28B
-19.78%-9.08B
-34.05%-4.47B
-32.62%-7.58B
-26.01%-3.33B
-15.05%-5.71B
-14.44%-2.64B
-36.59%-4.97B
-49.02%-2.31B
-113.23%-3.64B
Gross profit
-0.40%2.26B
1.73%4.57B
-4.52%2.27B
7.02%4.49B
0.72%2.38B
18.16%4.2B
37.92%2.36B
11.79%3.55B
4.18%1.71B
22.68%3.18B
Selling expenses
-13.36%-181.12M
10.06%-397.17M
29.24%-159.77M
4.42%-441.6M
13.38%-225.79M
-21.46%-462.01M
-44.40%-260.68M
5.98%-380.39M
-4.68%-180.53M
-4.48%-404.59M
Administrative expenses
-12.42%-616.16M
-27.84%-1.17B
-24.37%-548.08M
-23.55%-914M
-15.97%-440.69M
-20.51%-739.75M
-48.18%-380.02M
-39.07%-613.87M
-40.48%-256.46M
-80.65%-441.41M
Impairment and provision
-14.90%-109.08M
37.46%-192.1M
31.00%-94.93M
3.49%-307.14M
19.88%-137.59M
-28.61%-318.24M
-44.40%-171.73M
-5.20%-247.45M
-29.89%-118.93M
-61.11%-235.21M
-Other impairment is provision
-14.90%-109.08M
37.46%-192.1M
31.00%-94.93M
3.49%-307.14M
19.88%-137.59M
-28.61%-318.24M
-44.40%-171.73M
-5.20%-247.45M
-29.89%-118.93M
-61.11%-235.21M
Operating interest expense
----
----
----
----
-5.61%-13.77M
4.67%-29.13M
6.82%-13.04M
---30.56M
---13.99M
----
Special items of operating profit
154.68%269.96M
179.86%84.73M
265.97%106M
-484.00%-106.1M
8.48%-63.86M
-61.60%27.63M
-242.80%-69.78M
-41.28%71.95M
-507.82%-20.36M
168.52%122.53M
Operating profit
3.25%1.63B
6.36%2.9B
5.15%1.58B
1.77%2.73B
2.08%1.5B
13.78%2.68B
30.69%1.47B
6.00%2.35B
-5.99%1.12B
19.44%2.22B
Financing cost
-32.37%-22.39M
-9.56%-39.05M
---16.91M
---35.65M
----
----
----
----
----
---11.98M
Share of profits of associates
38.02%-2.14M
-59,008.33%-7.07M
-3,736.67%-3.45M
-93.75%12K
-168.70%-90K
-26.72%192K
173.60%131K
-57.67%262K
---178K
--619K
Share of profit from joint venture company
82.02%15.78M
-0.01%13.45M
46.16%8.67M
-1.63%13.45M
-15.32%5.93M
23.35%13.67M
44.54%7M
292.95%11.09M
--4.85M
--2.82M
Earning before tax
3.46%1.62B
6.03%2.87B
3.97%1.56B
0.43%2.7B
1.98%1.5B
13.82%2.69B
30.79%1.48B
6.92%2.37B
-5.51%1.13B
18.98%2.21B
Tax
0.87%-366.5M
-8.07%-667.14M
-12.57%-369.72M
6.66%-617.33M
6.16%-328.44M
-20.00%-661.34M
-30.98%-349.99M
4.57%-551.1M
16.88%-267.22M
-13.59%-577.47M
After-tax profit from continuing operations
4.81%1.25B
5.42%2.2B
1.56%1.19B
2.73%2.09B
4.52%1.18B
11.94%2.03B
30.73%1.13B
10.98%1.81B
-1.32%860.98M
21.01%1.63B
Earning after tax
4.81%1.25B
5.42%2.2B
1.56%1.19B
2.73%2.09B
4.52%1.18B
11.94%2.03B
30.73%1.13B
10.98%1.81B
-1.32%860.98M
21.01%1.63B
Minority profit
44.28%79.21M
-29.65%88.74M
7.30%54.9M
52.44%126.13M
28.02%51.17M
23.91%82.74M
124.84%39.97M
44.98%66.77M
64.08%17.78M
3,152.09%46.06M
Profit attributable to shareholders
2.90%1.17B
7.68%2.11B
1.30%1.14B
0.62%1.96B
3.65%1.13B
11.48%1.95B
28.74%1.09B
10.00%1.75B
-2.15%843.2M
17.47%1.59B
Basic earnings per share
3.45%0.6
7.00%1.07
0.00%0.58
1.01%1
1.75%0.58
3.13%0.99
23.91%0.57
10.34%0.96
-2.13%0.46
10.13%0.87
Diluted earnings per share
5.56%0.57
6.45%0.99
1.89%0.54
2.20%0.93
0.00%0.53
-5.21%0.91
15.22%0.53
10.34%0.96
-2.13%0.46
10.13%0.87
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Shinaga Chuwa Certified Public Accountants
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover -2.91%6.54B13.06%13.65B17.98%6.74B21.78%12.07B14.07%5.71B16.35%9.91B24.44%5.01B25.03%8.52B25.94%4.02B58.62%6.82B
Operating income -2.91%6.54B13.06%13.65B17.98%6.74B21.78%12.07B14.07%5.71B16.35%9.91B24.44%5.01B25.03%8.52B25.94%4.02B58.62%6.82B
Cost of sales 4.19%-4.28B-19.78%-9.08B-34.05%-4.47B-32.62%-7.58B-26.01%-3.33B-15.05%-5.71B-14.44%-2.64B-36.59%-4.97B-49.02%-2.31B-113.23%-3.64B
Operating expenses 4.19%-4.28B-19.78%-9.08B-34.05%-4.47B-32.62%-7.58B-26.01%-3.33B-15.05%-5.71B-14.44%-2.64B-36.59%-4.97B-49.02%-2.31B-113.23%-3.64B
Gross profit -0.40%2.26B1.73%4.57B-4.52%2.27B7.02%4.49B0.72%2.38B18.16%4.2B37.92%2.36B11.79%3.55B4.18%1.71B22.68%3.18B
Selling expenses -13.36%-181.12M10.06%-397.17M29.24%-159.77M4.42%-441.6M13.38%-225.79M-21.46%-462.01M-44.40%-260.68M5.98%-380.39M-4.68%-180.53M-4.48%-404.59M
Administrative expenses -12.42%-616.16M-27.84%-1.17B-24.37%-548.08M-23.55%-914M-15.97%-440.69M-20.51%-739.75M-48.18%-380.02M-39.07%-613.87M-40.48%-256.46M-80.65%-441.41M
Impairment and provision -14.90%-109.08M37.46%-192.1M31.00%-94.93M3.49%-307.14M19.88%-137.59M-28.61%-318.24M-44.40%-171.73M-5.20%-247.45M-29.89%-118.93M-61.11%-235.21M
-Other impairment is provision -14.90%-109.08M37.46%-192.1M31.00%-94.93M3.49%-307.14M19.88%-137.59M-28.61%-318.24M-44.40%-171.73M-5.20%-247.45M-29.89%-118.93M-61.11%-235.21M
Operating interest expense -----------------5.61%-13.77M4.67%-29.13M6.82%-13.04M---30.56M---13.99M----
Special items of operating profit 154.68%269.96M179.86%84.73M265.97%106M-484.00%-106.1M8.48%-63.86M-61.60%27.63M-242.80%-69.78M-41.28%71.95M-507.82%-20.36M168.52%122.53M
Operating profit 3.25%1.63B6.36%2.9B5.15%1.58B1.77%2.73B2.08%1.5B13.78%2.68B30.69%1.47B6.00%2.35B-5.99%1.12B19.44%2.22B
Financing cost -32.37%-22.39M-9.56%-39.05M---16.91M---35.65M-----------------------11.98M
Share of profits of associates 38.02%-2.14M-59,008.33%-7.07M-3,736.67%-3.45M-93.75%12K-168.70%-90K-26.72%192K173.60%131K-57.67%262K---178K--619K
Share of profit from joint venture company 82.02%15.78M-0.01%13.45M46.16%8.67M-1.63%13.45M-15.32%5.93M23.35%13.67M44.54%7M292.95%11.09M--4.85M--2.82M
Earning before tax 3.46%1.62B6.03%2.87B3.97%1.56B0.43%2.7B1.98%1.5B13.82%2.69B30.79%1.48B6.92%2.37B-5.51%1.13B18.98%2.21B
Tax 0.87%-366.5M-8.07%-667.14M-12.57%-369.72M6.66%-617.33M6.16%-328.44M-20.00%-661.34M-30.98%-349.99M4.57%-551.1M16.88%-267.22M-13.59%-577.47M
After-tax profit from continuing operations 4.81%1.25B5.42%2.2B1.56%1.19B2.73%2.09B4.52%1.18B11.94%2.03B30.73%1.13B10.98%1.81B-1.32%860.98M21.01%1.63B
Earning after tax 4.81%1.25B5.42%2.2B1.56%1.19B2.73%2.09B4.52%1.18B11.94%2.03B30.73%1.13B10.98%1.81B-1.32%860.98M21.01%1.63B
Minority profit 44.28%79.21M-29.65%88.74M7.30%54.9M52.44%126.13M28.02%51.17M23.91%82.74M124.84%39.97M44.98%66.77M64.08%17.78M3,152.09%46.06M
Profit attributable to shareholders 2.90%1.17B7.68%2.11B1.30%1.14B0.62%1.96B3.65%1.13B11.48%1.95B28.74%1.09B10.00%1.75B-2.15%843.2M17.47%1.59B
Basic earnings per share 3.45%0.67.00%1.070.00%0.581.01%11.75%0.583.13%0.9923.91%0.5710.34%0.96-2.13%0.4610.13%0.87
Diluted earnings per share 5.56%0.576.45%0.991.89%0.542.20%0.930.00%0.53-5.21%0.9115.22%0.5310.34%0.96-2.13%0.4610.13%0.87
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Shinaga Chuwa Certified Public Accountants--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data